Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer
US11078277B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 1, 2017 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Sep 3, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70517
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer. In particular, the present invention relates to a method of enhancing the CD8+ T cell-dependent immune response in a subject suffering from cancer comprising administering to the subject a therapeutically effective amount of an agent capable of increasing intra-tumoral ceramide content.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.